Decode everygenomewith precision.
Built in Hyderabad, trusted by 532+ institutions worldwide — AI/ML-ready sequencing and bioinformatics on one integrated, in-house multi-platform stack.
Powered by world-class technology partners
Six omics platforms,
one seamless workflow
From genomes to proteins, every platform shares the same quality-controlled pipeline — designed for researchers who need depth, speed and reproducibility.
Genomics
Pan-genome & de novo assembly, resequencing, optical mapping and single-cell DNA.
Transcriptomics
mRNA, small RNA, whole-transcriptome, single-cell and circular RNA profiling.
Metagenomics
Shotgun, 16S rRNA, metatranscriptome, microbial and viral genome sequencing.
Epigenomics
WGBS, RRBS, ChIP-Seq and targeted methylation panels for regulatory insight.
Proteomics
Global discovery, quantitative, PTM and protein–protein interaction analysis.
Metabolomics
Small-molecule profiling that reveals biochemical activity and pathways — services launching soon.
Solving complex biological questions through precision genomics
We combine high-throughput sequencing with computational analysis to interpret complex biological data and accelerate discovery across life-science domains.
- PacBio HiFi, Oxford Nanopore and short-read platforms
- Rigorous QC at every stage, flagged — never silently carried forward
- AI-assisted interpretation and multi-omics integration
- Secure delivery of raw, intermediate and final data
Consult & design
We shape the study around your objectives, organism and samples.
Sample to sequence
Library prep and sequencing on the right platform for the question.
Compute & analyse
Alignment, assembly, variant calling and expression analysis.
Insight & delivery
AI-driven interpretation and integrated, publication-ready outputs.
From rare disease to oncology —
answers in the genome
Clinically focused panels and whole-genome assays that support diagnosis, prognosis and personalised care.
Inherited Disorders
Comprehensive screening to uncover the genetic basis of rare and inherited conditions.
Cancer Genomics
Tumour profiling and liquid-biopsy assays that guide targeted therapy decisions.
One integrated, in-house platform stack
HiFi long read, ultra-long nanopore and short read, with automated sample and library prep — all under one roof in Hyderabad, matched to each study design.
Our major focus
AI/ML-ready from the first read. In 2019 we installed the first PacBio Sequel II in South Asia.